Kenrox Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-05-2024
- Paid Up Capital ₹ 0.10 M
as on 26-05-2024
- Company Age 5 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 88.15%
(FY 2022)
- Profit 56.95%
(FY 2022)
- Ebitda -75.88%
(FY 2022)
- Net Worth 36.00%
(FY 2022)
- Total Assets 48.31%
(FY 2022)
About Kenrox Healthcare
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shashi Bala and Balinder Kumar serve as directors at the Company.
- CIN/LLPIN
U24299HR2019PTC084059
- Company No.
084059
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2019
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Kurukshetra, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Kenrox Healthcare Private Limited offer?
Kenrox Healthcare Private Limited offers a wide range of products and services, including Respiratory System Drugs, Anti Asthma Drug, Cardiovascular Drugs & Medication, Cardiac Drugs, Pharma & Bioanalytical Services, PCD Pharma Franchise.
Who are the key members and board of directors at Kenrox Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shashi Bala  | Director | 10-Dec-2019 | Current |
| Balinder Kumar | Director | 10-Dec-2019 | Current |
Financial Performance of Kenrox Healthcare.
Kenrox Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 88.15% increase. The company also saw a substantial improvement in profitability, with a 56.95% increase in profit. The company's net worth Soared by an impressive increase of 36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kenrox Healthcare?
Unlock access to Kenrox Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Elkos Healthcare Private LimitedActive 14 years 11 monthsShashi Bala and Balinder Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kenrox Healthcare?
Unlock and access historical data on people associated with Kenrox Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kenrox Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kenrox Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
